Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRE-8: Trifluridine/Tipiracil + Panitumumab vs Bevacizumab in mCRC
NCT05007132Phase 2Recruiting
- Start
- Dec 2021
- Primary completion
- Dec 2029
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in metastatic colorectal cancer (mCRC). Started Dec 2021; status: recruiting.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05007132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007132.